Technical peptide guides, head-to-head comparisons, and buyer's-checklist writeups. Written for researchers evaluating compounds, sources, and testing documentation.
Research Clusters
Three clusters map the current novel-compound landscape — the triple agonist, the targeted-adipocyte investigational peptide, and the head-to-head comparison. All content is for laboratory research use only.
Triple Agonist & Sourcing
UBT251 is a triple-receptor agonist peptide engineered to engage the GLP-1, GIP, and glucagon receptor classes in a single backbone. The cluster covers the published structural profile, lyophilized handling notes, and what a lab should verify before sourcing: sequence identity, LC-MS and HPLC lot documentation, endotoxin results, and USA manufacture. PX1 supplies UBT251 as 10mg and 20mg research vials with lot-tracked certificates in the COA archive.
Targeted Adipocyte Apoptosis
CBL-514 is an investigational peptide studied in preclinical models for selective adipocyte-targeted apoptosis pathways. The cluster gathers the mechanism literature, formulation and reconstitution notes, and the documentation set a research team should expect with any lot: identity, purity, and sterility results from an accredited laboratory. PX1 supplies CBL-514 as a 10mg research vial, lot-tracked and independently tested.
UBT-251 vs Retatrutide
A side-by-side research comparison of UBT251 and Retatrutide: receptor-class coverage, backbone design, molecular profile, and supplied format. The comparison also maps where the two compounds differ as research materials — sourcing depth, lot documentation, and published handling data — so a lab can evaluate both strictly as research peptides.
KPV is a C-terminal tripeptide of α-MSH studied for anti-inflammatory endpoints in colitis and skin models. Mechanism and lab handling.
Read MoreGHK-Cu is a naturally occurring tripeptide-copper complex studied for skin, wound-healing, and gene-modulation endpoints. Chemistry and handling.
Read MoreTB-500 is a synthetic fragment of Thymosin Beta-4 studied for actin sequestration, angiogenesis, and tissue-repair endpoints in animal models.
Read MoreHow to reconstitute lyophilized peptides, choose a diluent, calculate concentrations, and handle vials sterilely in a research setting.
Read MoreSurvodutide (BI 456906) is a GLP-1/glucagon dual agonist in Phase 3 (SYNCHRONIZE) trials. Mechanism, published data, and where it fits.
Read MoreMazdutide (IBI362 / LY3305677) is a GLP-1/glucagon dual agonist in late-stage development in China. Mechanism, DREAMS trial data, and handling.
Read MoreTwo closely related growth-hormone-releasing peptides with different appetite and prolactin/cortisol profiles. Mechanism and handling.
Read MoreThymosin Alpha-1 (Tα1) is a 28-residue peptide studied for immune modulation. Mechanism, TLR signaling, and purity considerations.
Read MoreCagrilintide is a long-acting amylin analog under Phase 3 development for obesity. Mechanism, monotherapy data, and combination with PX1-S.
Read More
